US Bancorp’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

US Bancorp’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$5K	–	4217
2021 Q2	$5K	Hold	1,000	–	–	﹤0.01%	3641
2021 Q1	$5K	Buy	+1,000	New	+$5.47K	﹤0.01%	3527
2018 Q4	–	Sell	-100	Closed	–	–	3740
2018 Q3	$0	Hold	100	–	–	﹤0.01%	3730
2018 Q2	$0	Hold	100	–	–	﹤0.01%	3722
2018 Q1	$0	Hold	100	–	–	﹤0.01%	3725
2017 Q4	$0	Hold	100	–	–	﹤0.01%	3699
2017 Q3	$0	Hold	100	–	–	﹤0.01%	3666
2017 Q2	$0	Hold	100	–	–	﹤0.01%	3637
2017 Q1	$0	Hold	100	–	–	﹤0.01%	3666
2016 Q4	$0	Hold	100	–	–	﹤0.01%	3672
2016 Q3	$0	Hold	100	–	–	﹤0.01%	3649
2016 Q2	$0	Hold	100	–	–	﹤0.01%	3671
2016 Q1	$0	Hold	100	–	–	﹤0.01%	3693
2015 Q4	$0	Hold	100	–	–	﹤0.01%	3735
2015 Q3	$0	Hold	100	–	–	﹤0.01%	3699
2015 Q2	$0	Hold	100	–	–	﹤0.01%	3665
2015 Q1	$0	Hold	100	–	–	﹤0.01%	3653
2014 Q4	$1K	Hold	100	–	–	﹤0.01%	3480
2014 Q3	$1K	Hold	100	–	–	﹤0.01%	3456
2014 Q2	$1K	Hold	100	–	–	﹤0.01%	3443
2014 Q1	$1K	Hold	100	–	–	﹤0.01%	3427
2013 Q4	$2K	Hold	100	–	–	﹤0.01%	3314
2013 Q3	$3K	Hold	100	–	–	﹤0.01%	3158
2013 Q2	$3K	Buy	+100	New	+$3.44K	﹤0.01%	3108

Other funds holding STAB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

US Bancorp's STAB Position: Q3 2021 in Review

US Bancorp sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2021, closing a stake of 1,000 shares — an estimated $5K sold.

US Bancorp first reported a position in STAB in Q2 2013 and held it in 24 quarters. The position peaked at $5K in Q2 2021. 23 funds tracked by Wall St. Rank hold STAB as of Q3 2021.

US Bancorp reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
US Bancorp sold 1,000 Statera Biopharma, Inc. Common Stock shares in Q3 2021, an estimated $5K.
US Bancorp first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
US Bancorp's Statera Biopharma, Inc. Common Stock position peaked at $5K in Q2 2021.
23 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2021.

Based on US Bancorp's 13F filing for Q3 2021, filed 10 Nov 2021.